We also tested a general γ-secretase inhibitor, DBZ, which is known to block Notch signaling and elicit strong effects on tumor and retina angiogenesis6, similarly to anti-Dll4 treatment (Extended Data Fig. 5g). The gene discussed is DLL4; the disease is neoplasm.